Home » Topics » Regulatory

Regulatory
RSS

FDA approves Fycompa for partial-onset seizures in pediatric patients

Oct. 1, 2018

Sanwa Kagaku Kenkyusho obtains approval for Metoana in Japan

Oct. 1, 2018

FDA approves Vizimpro for first-line treatment of metastatic NSCLC with EGFR mutations

Sep. 28, 2018

FDA approves Emgality for preventive treatment of migraine in adults

Sep. 28, 2018

European Commission approves pegfilgrastim biosimilar Udenyca

Sep. 26, 2018

FDA grants approval for Copiktra for CLL/SLL, accelerated approval in follicular lymphoma

Sep. 25, 2018

Xospata approved in Japan for FLT3 mutation-positive relapsed or refractory AML

Sep. 25, 2018

Beova granted marketing approval in Japan for overactive bladder

Sep. 25, 2018

Eybelis granted marketing approval for glaucoma and ocular hypertension in Japan

Sep. 25, 2018

Lorlatinib receives first approval in Japan

Sep. 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...